Navigation Links
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M
Date:8/22/2013

SCHOFIELD, Wis., Aug. 22, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it will sponsor the 5th Miles for Migraine Race San Francisco by supplying $5,000 of LipiGesic M for the participants.

Miles for Migraine, a registered 501c3 nonprofit, will host the 5th Miles for Migraine race on September 14, 2013 in San Francisco. "We are honored to be part of the effort to increase the awareness of migraine," said Russ Mitchell, CEO PuraMed BioScience. "Miles for Migraine and PuraMed BioScience share the same goal: to improve the lives of people who suffer with migraine. It's a great fit.

"We hope that we will not only help increase awareness, but also hope that by donating LipiGesic M that we will give the runners a tool for migraine treatment that stops migraine pain," said Mitchell.

LipiGesic M is a homeopathic formulation of feverfew and ginger delivered in a sublingual gel. Clinical trial results show that LipiGesic M has an efficacy rate that exceeds the number-one-selling triptan medication. In addition, LipiGesic M has not been shown, in the clinical trial or in everyday use, to cause drowsiness or rebound headache even if a migraineur takes the medication frequently.

"More people suffer from migraine than diabetes and asthma combined; yet it receives a fraction of funding for research," said Miles for Migraine Executive Director Joanne Fedeyko. "With local and national growth key to our mission of raising awareness, I'm thrilled San Francisco will once again host Miles for Migraine and help spread the word that migraine is more than 'just a headache.' With one in four American families impacted by migraine, we know that there is a huge population to get behind our cause."

Migraine is the leading brain disorder in the United States. Over 50 million American adults, teens, and children suffer from migraines or sinus headaches, which are often misdiagnosed migraines. In a 2004 report, the World Health Organization (WHO) classified severe migraine in the same category of disability with quadriplegia or terminal stage cancer.

General Event Information for 2013
The 5th Miles for Migraine San Francisco race takes place on Saturday September 14th at 8 a.m. in Golden Gate Park, in San Francisco, California. Fees range from $31 for the 2-Mile Walk to $41 for the 10K. Register online at www.milesformigraine.org

Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Patricia McMurtrie, VP Marketing
715-571-4910
patricia@PuramedBioScience.com
www.PuramedBioScience.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
7. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
8. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
9. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
10. Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
11. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):